0001209191-18-009177.txt : 20180212 0001209191-18-009177.hdr.sgml : 20180212 20180212161437 ACCESSION NUMBER: 0001209191-18-009177 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180101 FILED AS OF DATE: 20180212 DATE AS OF CHANGE: 20180212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Suesskind Dan S CENTRAL INDEX KEY: 0001303873 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 18596516 MAIL ADDRESS: STREET 1: C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. STREET 2: 5 BASEL STREET, P.O. BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2018-01-01 2018-01-02 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001303873 Suesskind Dan S C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 1 0 0 0 Put Option (Obligation to buy) 25.00 2017-04-04 2018-01-19 Ordinary Shares 19700 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The Form 3 of the Reporting Person originally filed on January 2, 2018 inadvertently omitted the Put option reported herein. Such Put option was beneficially owned by the Reporting Person prior to such Reporting Person's membership on the Issuer's Board of Directors. The Put option expired on January 19, 2018 and such expiration was reported on a Form 4 filed on January 23, 2018. The Reporting Person does not own any other such Put options. /s/ Dov Bergwerk, as attorney-in-fact for Dan S. Suesskind 2018-02-12